RAC 2.37% $1.65 race oncology ltd

the fact is that RAC has had huge growth in share price over the...

  1. 1,139 Posts.
    lightbulb Created with Sketch. 122
    the fact is that RAC has had huge growth in share price over the last 18 months, some 3000% I think. During the last few months of consolidation the team has developed many initiatives to prove the value of Zantrene. I believe these will enable further growth in the coming months, in the meantime I have 100% confidence that RAC leadership is developing the best strategy, and that they will know the best time to develop external PR. They have shown they know what to do so far and that they have the best skills, let’s let them get on with the nest stages towards commercialisation.

    short term SP growth is not the main prize here.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.